Tags

Type your tag names separated by a space and hit enter

Anticoagulation in continuous renal replacement therapy.
Dynamics. 2001 Winter; 12(4):13-7.D

Abstract

Continuous renal replacement therapy (CRRT) is a specialized intervention that is managed largely by critical care nurses who are educated in the theoretical and practical aspects of the therapy. CRRT is most commonly indicated for hemodynamically unstable patients who have acute renal failure and a narrow margin of tolerance for the rapid fluid shifts associated with traditional dialysis. Although the utilization of CRRT in the critical care setting is becoming more widespread, numerous factors need to be considered before therapy is initiated. The use of anticoagulation is a concern because of the associated risk of bleeding and thrombocytopenia. Nurses at the bedside must be expert in both managing CRRT and assisting in identifying patients who may be at potential risk when this form of treatment is in place. An overview of possible anticoagulants for use in CRRT is outlined in this article.

Authors+Show Affiliations

Hidalgo N
Cardiovascular Intensive Care Unit, Toronto General Hospital, Toronto, Ontario.
Hynes-Gay P
No affiliation info available
Hill S
No affiliation info available
Burry L
No affiliation info available

MeSH

AnticoagulantsCitric AcidHeparinHeparin, Low-Molecular-WeightHumansRenal Replacement TherapyRisk AssessmentRisk FactorsThrombocytopeniaTime Factors

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

11845482

Citation

Hidalgo, N, et al. "Anticoagulation in Continuous Renal Replacement Therapy." Dynamics (Pembroke, Ont.), vol. 12, no. 4, 2001, pp. 13-7.
Hidalgo N, Hynes-Gay P, Hill S, et al. Anticoagulation in continuous renal replacement therapy. Dynamics. 2001;12(4):13-7.
Hidalgo, N., Hynes-Gay, P., Hill, S., & Burry, L. (2001). Anticoagulation in continuous renal replacement therapy. Dynamics (Pembroke, Ont.), 12(4), 13-7.
Hidalgo N, et al. Anticoagulation in Continuous Renal Replacement Therapy. Dynamics. 2001;12(4):13-7. PubMed PMID: 11845482.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anticoagulation in continuous renal replacement therapy. AU - Hidalgo,N, AU - Hynes-Gay,P, AU - Hill,S, AU - Burry,L, PY - 2002/2/16/pubmed PY - 2002/10/3/medline PY - 2002/2/16/entrez SP - 13 EP - 7 JF - Dynamics (Pembroke, Ont.) JO - Dynamics VL - 12 IS - 4 N2 - Continuous renal replacement therapy (CRRT) is a specialized intervention that is managed largely by critical care nurses who are educated in the theoretical and practical aspects of the therapy. CRRT is most commonly indicated for hemodynamically unstable patients who have acute renal failure and a narrow margin of tolerance for the rapid fluid shifts associated with traditional dialysis. Although the utilization of CRRT in the critical care setting is becoming more widespread, numerous factors need to be considered before therapy is initiated. The use of anticoagulation is a concern because of the associated risk of bleeding and thrombocytopenia. Nurses at the bedside must be expert in both managing CRRT and assisting in identifying patients who may be at potential risk when this form of treatment is in place. An overview of possible anticoagulants for use in CRRT is outlined in this article. SN - 1497-3715 UR - https://www.unboundmedicine.com/medline/citation/11845482/Anticoagulation_in_continuous_renal_replacement_therapy_ L2 - https://medlineplus.gov/bloodthinners.html DB - PRIME DP - Unbound Medicine ER -